CRISPR Therapeutics AG (CRSP)
NASDAQ: CRSP · Real-Time Price · USD
56.18
-0.20 (-0.35%)
At close: May 29, 2026, 4:00 PM EDT
55.17
-1.01 (-1.80%)
After-hours: May 29, 2026, 7:58 PM EDT
Revenue by Segment
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
|---|
Discovering, Developing and Commercializing Therapies | 3.51M | 37.31M | 371.21M | 1.20M | 914.96M | | | | | |
Discovering, Developing and Commercializing Therapies Growth | -90.59% | -89.95% | 30885.48% | -99.87% | 127154.94% | | | | | |
| 3.51M | 37.31M | 371.21M | 1.20M | 914.96M | | | | | |
| -90.59% | -89.95% | 30885.48% | -99.87% | 127154.94% | | | | | |
Source: S&P Global Market Intelligence.
